Scott Bonham serves as an Advisory Board member for Cell Therapy Foundation. Scott Bonham is a co-founder of GGV Capital, a $1 billion venture capital firm that invests in the US and China. He has worked in the technology industry for more than 20 years, and has successfully invested across a wide variety of global industries ranging from biotech to information technology and across multiple geographies, including Silicon Valley, China, Israel and Europe. His underlying investment thesis is that technology advances can change the world, and he is looking forward to the day when adult stem cells are used as therapeutic solutions. Scott is a graduate of Queen's University, Canada and Harvard Business School.